January 6, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has forwarded its first shipment of...
November 16, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) wishes to announce that Matica and its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), have reached an agreement...
November 2, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has received approval to supply...
September 08, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), has received approval from Health...
August 14, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), has been informed by Health Canada...
July 2, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to welcome Mr. Ali Gerba to the board of directors of the Company, subject to regulatory approval. Mr. Gerba brings...
